arrow_back Back Filing freshness 10-Q Q3 FY2024 SEC EDGAR

VERDE BIO HOLDINGS, INC.

APHD
— Price unavailable
Energy ·Crude Petroleum & Natural Gas ·USCrude Petroleum & Natural Gas
53 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

VERDE BIO HOLDINGS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth None
Op. Margin —
ROIC -272.5% ↘
FCF / Share $-0.00
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close.

53-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.32K
— —
Net Income Profit after all expenses
$-1.49M
↓ -239.5% —
FCF / Share Free cash flow per share
$-0.00
↑ +24.5% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
9
Cash Quality ↑
74

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 13 years · 53 quarters